25 Leading Veterinary Vaccines Companies Shaping Innovation and Market Growth to 2030

Discover the top 25 companies driving innovation in the Veterinary Vaccines market. This in-depth analysis explores competitive advantages, transformative trends, and key players poised to influence global animal health through 2030. Access the comprehensive market research report at MarketsandMarkets for further insights.

Spotlights on the Industry's Top Veterinary Vaccines Companies

The veterinary vaccines market is advancing at a robust pace, propelled by rising global livestock populations, intensifying awareness of zoonotic disease risks, expanding companion animal healthcare expenditure, and the emergence of novel vaccine technologies including recombinant, mRNA, and subunit platforms. Valued at USD 10.94 billion in 2024 and reaching USD 11.63 billion in 2025, the global veterinary vaccines market is projected to grow at a CAGR of 6.8% to reach USD 16.15 billion by 2030. This sustained growth reflects the critical role of immunological disease prevention in protecting animal health, agricultural productivity, and the food supply chain across both developed and rapidly developing economies. In this dynamic environment, the following 25 industry leaders stand out for their scientific depth, commercial reach, and transformative contributions to global veterinary immunology.

1. Zoetis

Zoetis is the world's largest animal health company and the undisputed leader in veterinary vaccines, with a comprehensive portfolio spanning livestock, poultry, and companion animal immunological products. Spun off from Pfizer, Zoetis brings world-class pharmaceutical R&D capabilities to veterinary medicine, continuously advancing next-generation vaccine technologies including mRNA-based platforms and precision immunology. Their global manufacturing network, deep distributor relationships, and relentless focus on disease prevention position Zoetis as the benchmark competitor against which all others in the veterinary vaccine market are measured.

2. Merck & Co., Inc.

Merck & Co., Inc., through its Merck Animal Health division, operates one of the most diversified and scientifically advanced veterinary vaccine portfolios in the world. Their RECOMBITEK, BOVILIS, and NOBIVAC product families address critical infectious disease challenges across cattle, swine, poultry, and companion animal species. Merck Animal Health's substantial investment in recombinant and novel adjuvant vaccine technologies, combined with a global commercial infrastructure spanning over 50 countries, ensures their continued relevance at the frontier of veterinary immunology.

3. Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH is a global pharmaceutical leader whose animal health division ranks among the top three veterinary vaccine producers worldwide. Their Ingelvac, Porcilis, and Suiseng product lines are widely recognized standards of care in swine health management, while their companion animal and cattle vaccine portfolios continue to expand. Boehringer Ingelheim's strong commitment to R&D, particularly in viral respiratory disease and reproductive health vaccines, reinforces their scientific leadership and long-term competitive positioning in the veterinary vaccine market.

4. Elanco

Elanco Animal Health is a major global animal health company with a growing veterinary vaccine business built substantially through its acquisition of Bayer Animal Health. Their vaccine portfolio addresses key infectious diseases in cattle, swine, poultry, and companion animals, complemented by a broad range of parasiticides and pharmaceuticals that support an integrated herd and flock health approach. Elanco's investment in digital animal health platforms and data-driven farm management tools creates additional value for producers seeking to optimize vaccination program performance and animal productivity.

5. Ceva

Ceva Santé Animale is a rapidly growing independent animal health company headquartered in France, with particular strength in poultry and swine vaccines across global markets. Their extensive biologics portfolio—spanning Marek's disease, Newcastle disease, infectious bronchitis, and major swine pathogens—is backed by dedicated vaccine R&D centers and manufacturing facilities on multiple continents. Ceva's agile commercial model, emphasis on local market adaptation, and strong relationships with integrators and producers across emerging poultry markets make them one of the most dynamic competitors in global veterinary vaccinology.

6. Virbac

Virbac is a French independent animal health company with a targeted veterinary vaccine strategy focused on companion animals, aquaculture, and select livestock species. Their vaccine portfolio includes products for canine, feline, equine, and fish health, supported by manufacturing sites in Europe, Australia, and the Americas. Virbac's independence, scientific focus, and strong presence in underserved species and geographic markets differentiate them from larger integrated animal health corporations, enabling a distinctive positioning in specialty and niche veterinary vaccine segments.

7. Phibro Animal Health Corporation

Phibro Animal Health Corporation is a US-based animal health company with significant veterinary vaccine capabilities focused primarily on poultry and swine production species. Their biologics division produces a range of inactivated and live attenuated vaccines addressing economically important viral and bacterial diseases in commercial livestock operations. Phibro's integrated approach—combining vaccines, nutritional products, and performance-enhancing solutions—supports producer clients seeking comprehensive herd and flock health management from a single trusted partner.

8. Hester Biosciences Limited

Hester Biosciences Limited is India's largest animal health company by vaccine production capacity, with a portfolio spanning poultry, livestock, and companion animal vaccines serving both domestic and international markets. Their manufacturing facilities, certified to international standards, produce a broad range of viral and bacterial vaccines that address priority disease challenges across South Asia, Africa, and Southeast Asia. Hester's strong government tender relationships, expanding export footprint, and growing R&D capabilities position them as a leading veterinary vaccine player in high-growth emerging markets.

9. HIPRA

HIPRA is a Spanish veterinary pharmaceutical company with a strong scientific identity and a comprehensive vaccine portfolio addressing swine, poultry, ruminant, and companion animal disease challenges. Their commitment to in-house vaccine R&D—encompassing inactivated, live attenuated, subunit, and novel platform technologies—has produced innovative products that have earned widespread adoption among European and international livestock producers. HIPRA's reputation for scientific rigor, regulatory excellence, and proactive disease surveillance partnerships with veterinary professionals distinguishes them as a trusted innovator in the global veterinary vaccines landscape.

10. Biogénesis Bagó

Biogénesis Bagó is a leading Latin American animal health company with a strong veterinary vaccine portfolio focused on cattle, poultry, and swine species across South American markets. Their biologics manufacturing capabilities and deep understanding of regional disease epidemiology enable them to develop and supply vaccines tailored to the specific infectious disease pressures faced by Latin American livestock producers. Biogénesis Bagó's strategic importance to the region's agricultural biosecurity, combined with growing international partnerships, supports their expansion beyond their established South American base.

11. Tianjin Ringpu Bio-Technology Co., Ltd.

Tianjin Ringpu Bio-Technology Co., Ltd. is a major Chinese veterinary biologics manufacturer producing a wide range of vaccines for poultry, swine, cattle, and aquaculture species. Their extensive product portfolio and large-scale manufacturing infrastructure support both the domestic Chinese market and growing export activities across Asia and beyond. Ringpu's investment in modern bioreactor technology, quality management systems, and new product development reflects the broader ambition of Chinese veterinary vaccine producers to compete on an increasingly global stage.

12. China Animal Husbandry Group

China Animal Husbandry Group (CAHG) is a state-backed Chinese enterprise and one of the country's most significant veterinary vaccine producers, with a mission spanning biosecurity, livestock productivity, and national food safety. CAHG's portfolio addresses priority animal disease threats including foot-and-mouth disease, highly pathogenic avian influenza, classical swine fever, and other strategically important pathogens. Their government relationships, national distribution infrastructure, and scale of production make CAHG a foundational pillar of China's veterinary vaccine supply system and an increasingly influential presence in global animal health.

13. Jinyu Biotechnology Co., Ltd.

Jinyu Biotechnology Co., Ltd. is an established Chinese animal health company with a focus on veterinary vaccines and biological products for cattle, swine, and poultry. Their manufacturing operations comply with Chinese GMP standards, supporting a substantial domestic customer base and growing international business activities. Jinyu's continued investment in product portfolio expansion and manufacturing quality infrastructure reflects the competitive dynamics of China's rapidly evolving veterinary biologics sector, where domestic producers are increasingly challenging international incumbents on quality as well as price.

14. Neogen Corporation

Neogen Corporation occupies a distinctive position in the animal health ecosystem, combining veterinary diagnostics, genomics, and biosecurity solutions with select vaccine and biological product capabilities. Their integrated approach to animal health management—linking disease detection, genetic selection, and prevention—provides a differentiated value proposition for livestock producers and food safety-focused customers. Neogen's strong diagnostics heritage and growing biological products business support their strategy of becoming a comprehensive animal health intelligence partner rather than a traditional standalone vaccine supplier.

15. Vaxxinova International B.V.

Vaxxinova International B.V. is a specialized veterinary vaccine company focused on custom-made autogenous vaccines and conventional biologics for poultry, swine, and cattle producers. Their expertise in autogenous vaccine development—producing tailored immunological products from field-isolated strains—addresses endemic disease challenges that conventional commercial vaccines may not fully cover. Vaxxinova's scientific specialization, flexible manufacturing capabilities, and strong relationships with large-scale integrated producers position them as an essential niche player in the global veterinary vaccine market.

16. Endovac Animal Health

Endovac Animal Health is a US-based veterinary biologics company specializing in innovative immunostimulant and vaccine adjuvant technologies with applications across bovine, swine, and equine health. Their proprietary ENABL adjuvant platform enhances vaccine performance and duration of immunity, offering livestock producers and veterinarians meaningful improvements in disease protection outcomes. Endovac's focused technology strategy and collaborative approach with producers and veterinary practitioners support their growth in specialty biologics segments where conventional vaccine performance falls short.

17. Brilliant Bio Pharma Private Limited

Brilliant Bio Pharma Private Limited is an Indian veterinary biologics company producing a range of vaccines and biological products for poultry, livestock, and companion animals. Their manufacturing facilities operate under regulatory frameworks aligned with Indian and international quality standards, supporting both domestic supply and selected export markets across South and Southeast Asia. Brilliant Bio Pharma's expanding product portfolio and manufacturing investments reflect the strong growth dynamics of India's veterinary vaccine sector, driven by rising livestock populations and increasing awareness of preventive animal healthcare.

18. Aptimmune

Aptimmune is an innovative veterinary vaccine company developing novel immunological approaches to address persistent disease challenges in livestock and poultry production. Their focus on cutting-edge antigen discovery, novel delivery platforms, and evidence-based vaccine design reflects a commitment to advancing the science of veterinary immunology beyond conventional approaches. Aptimmune's pipeline of next-generation veterinary vaccines targets pathogens where current commercial products provide suboptimal protection, positioning them as a scientifically differentiated challenger in specialty veterinary biologics.

19. Indian Immunologicals Ltd.

Indian Immunologicals Ltd. (IIL) is one of India's oldest and most respected veterinary vaccine manufacturers, with a diversified portfolio spanning foot-and-mouth disease, rabies, bovine, poultry, and companion animal vaccines. As a subsidiary of the National Dairy Development Board, IIL benefits from deep institutional relationships with India's dairy sector and a mission-driven focus on supporting national livestock health and food security. Their expanding international business across Asia, Africa, and the Middle East reflects growing global recognition of IIL's quality manufacturing capabilities and competitive product offerings.

20. Torigen Pharmaceuticals Inc.

Torigen Pharmaceuticals Inc. is a US-based veterinary biotech company specializing in personalized cancer immunotherapy and autogenous tumor vaccines for companion animals, particularly dogs and cats. Their proprietary tumor cell lysate vaccine platform enables veterinary oncologists to provide customized immunological treatment options for pets with cancer, addressing an unmet clinical need in companion animal oncology. Torigen's focus on the rapidly growing pet health premium segment and the intersection of veterinary and human oncology research positions them as a pioneering innovator in companion animal biologics.

21. Kyoritsuseiyaku Corporation

Kyoritsuseiyaku Corporation is a Japanese veterinary pharmaceutical and vaccine company with a portfolio addressing companion animal and livestock disease prevention across the Japanese domestic market and select international territories. Their product line includes vaccines for dogs, cats, cattle, and swine, developed and manufactured in compliance with Japanese regulatory standards recognized for their rigor and precision. Kyoritsuseiyaku's scientific expertise, strong veterinary practitioner relationships, and quality manufacturing reputation support their sustained relevance in Japan's premium veterinary healthcare market.

22. Intas Pharmaceuticals Ltd.

Intas Pharmaceuticals Ltd. is a major Indian pharmaceutical company with a growing animal health division that includes veterinary vaccines and biologics for livestock and companion animals. Their animal health business leverages Intas's substantial pharmaceutical manufacturing infrastructure and regulatory expertise to deliver quality veterinary immunological products across India and international markets. Intas's expanding veterinary biologics portfolio and distribution capabilities reflect their strategic recognition of the strong growth potential in India's evolving animal healthcare market.

23. Ourofino Saúde Animal

Ourofino Saúde Animal is a leading Brazilian animal health company with a growing veterinary vaccine portfolio serving cattle, swine, poultry, and companion animal markets across Latin America. Their biologics division produces vaccines addressing key infectious disease challenges in Brazil's vast and economically vital livestock sector, supported by modern manufacturing facilities and a strong national distribution network. Ourofino's commitment to innovation, regulatory excellence, and deep understanding of Brazilian and Latin American animal disease epidemiology positions them as an essential regional partner for livestock producers and veterinary professionals.

24. Biovac Ltd.

Biovac Ltd. is a South African biologics company with a veterinary vaccine manufacturing capability serving both the domestic South African market and the broader African continent. Their veterinary products address priority animal disease threats in the region, supporting livestock health and agricultural productivity in markets where robust disease prevention is critical to food security and rural livelihoods. Biovac's government partnerships, local manufacturing capability, and knowledge of African animal disease ecology make them a strategically important veterinary vaccine producer for the continent's growing animal health market.

25. Laboratoire LCV

Laboratoire LCV is a French veterinary biologics company specializing in the development and production of autogenous vaccines and custom immunological products for livestock and poultry producers. Their flexible manufacturing capabilities and scientific expertise in strain isolation, characterization, and vaccine formulation enable rapid response to emerging or endemic disease challenges that fall outside the coverage of conventional commercial vaccines. Laboratoire LCV's established relationships with French and European veterinary practitioners and producer groups support a loyal and growing customer base in the specialty veterinary vaccine segment.